Antioxidant therapy prevents devastating vision loss when added to standard-of-care on rare birth defect

Light microscopy image of treated and untreated retinal cells

Light microscopy images of retinas from animal model of Smith-Lemli-Opitz Syndrome (SLOS). Treatment with antioxidant combination therapy (right) preserved normal retinal structure and prevented degeneration and death of photoreceptor cells (rods and cones). Credit: Steven Fliesler

Findings suggest more effective potential therapies for Smith-Lemli-Opitz Syndrome

Release Date: February 2, 2018